FUQA:LSE:LSE-Fidelity US Quality Income ETF Acc (GBX)

ETF | Others |

Last Closing

USD 901.5

Change

-1.63 (-0.18)%

Market Cap

N/A

Volume

854.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
FUQA:LSE
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+13.40 (+7.84%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.04%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.01 (+0.04%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+1.60 (+1.54%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.10 (-1.48%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 259.48B
0QZO:LSE 0QZO

+3.90 (+4.55%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.30 (+0.91%)

USD 202.26B
0R24:LSE Intel Corp.

+1.51 (+7.71%)

USD 196.14B

ETFs Containing FUQA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.83% 18% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.83% 18% F 27% F
Trailing 12 Months  
Capital Gain -0.43% 35% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.43% 33% F 44% F
Trailing 5 Years  
Capital Gain 83.62% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.62% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.66% 79% B- 79% B-
Dividend Return 14.66% 79% B- 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.57% 72% C 85% B
Risk Adjusted Return 171.14% 100% F 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike